Core One Labs will showcase its proprietary biosynthetic psilocybin technology at the Investor Hall event on August 4, 2021 – QNT Press Release

[ad_1]

Vancouver, British Columbia, July 17, 2021 (Global News Agency) – Core One Laboratory Company (Comprehensive Education:Cool), (Over-the-counter transactions:CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core one“Or”the company“) is pleased to announce that Dr. Robert EW Hancock, Chairman of the Board and CEO of its wholly-owned subsidiary Vocan Biotechnologies Inc. (“Make a call“) will deliver a speech at a virtual city hall meeting hosted by the company on Wednesday, August 4, 2021 at 1:30 pm Pacific Standard Time / 4:30 pm Eastern Time / 22:30 pm Central European Time.

The virtual town hall event will include a presentation by Dr. Hancock on the status of Vocan’s biosynthetic psilocybin production and will include live videos from the company-operated laboratory in Victoria, British Columbia. Dr. Hancock will also answer questions from investors.

2021 is an important year for Core One Labs. Our team has been very focused on building a company that we truly believe to be the first in the field of psychedelics. Our multi-faceted business model envisages a company that solves the complete psychedelic cycle; from research on proprietary product development, development and implementation of appropriate clinical trial research, and treatment of clients in various journeys to achieve sustained mental health demand,“The company’s chief executive Joel Shacker (Joel Shacker) said.

This is what each of our team members…

The full story on Benzinga.com

[ad_2]

Source link